(2012). JS-K, a glutathione/glutathione S-transferaseactivated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells. BMC Cancer, 12(1), 130. https://doi.org/10.1186/1471-2407-12-130
Chicago Style (17th ed.) Citation"JS-K, a Glutathione/glutathione S-transferaseactivated Nitric Oxide Releasing Prodrug Inhibits Androgen Receptor and WNT-signaling in Prostate Cancer Cells." BMC Cancer 12, no. 1 (2012): 130. https://doi.org/10.1186/1471-2407-12-130.
MLA (9th ed.) Citation"JS-K, a Glutathione/glutathione S-transferaseactivated Nitric Oxide Releasing Prodrug Inhibits Androgen Receptor and WNT-signaling in Prostate Cancer Cells." BMC Cancer, vol. 12, no. 1, 2012, p. 130, https://doi.org/10.1186/1471-2407-12-130.
Warning: These citations may not always be 100% accurate.
